glycopyrrolate has been researched along with Alzheimer Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajo, R; Canuet, L; López, ME; Maestú, F; Osipova, D; Pekkonen, E; Pereda, E; Pusil, S | 1 |
| Hirvonen, J; Huttunen, J; Jääskeläinen, IP; Kaakkola, S; Pekkonen, E | 1 |
| Cowen, PJ; Geaney, DP; Shepstone, BJ; Soper, N | 1 |
| Chase, TN; Mohr, E; Mouradian, MM; Williams, JA | 1 |
2 trial(s) available for glycopyrrolate and Alzheimer Disease
| Article | Year |
|---|---|
Auditory sensory memory and the cholinergic system: implications for Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Attention; Cerebral Cortex; Cholinergic Fibers; Contingent Negative Variation; Dominance, Cerebral; Double-Blind Method; Evoked Potentials, Auditory; Female; Glycopyrrolate; Humans; Infusions, Intravenous; Magnetoencephalography; Male; Memory, Short-Term; Pitch Perception; Reference Values; Scopolamine; Signal Processing, Computer-Assisted | 2001 |
No response to high-dose muscarinic agonist therapy in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Double-Blind Method; Female; Glycopyrrolate; Humans; Male; Middle Aged; Parasympathomimetics; Placebos; Succinimides | 1988 |
2 other study(ies) available for glycopyrrolate and Alzheimer Disease
| Article | Year |
|---|---|
Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Female; Glycopyrrolate; Humans; Magnetoencephalography; Male; Middle Aged; Neural Pathways; Placebo Effect; Rest; Scopolamine | 2015 |
Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Cerebrovascular Circulation; Drug Evaluation; Female; Glycopyrrolate; Humans; Infusions, Intravenous; Male; Middle Aged; Organotechnetium Compounds; Oximes; Parasympathetic Nervous System; Parietal Lobe; Physostigmine; Technetium Tc 99m Exametazime; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 1990 |